Skip to main content

Table 3 Non-celiac findings in patients with multiple biopsy sites

From: Limited utilization of serologic testing in patients undergoing duodenal biopsy for celiac disease

Non-duodenal findings in patients with positive pre-biopsy serology Duodenal findings in patients with negative pre-biopsy serology
Finding Site N % Finding N %
Chronic gastritis S 18 26% IVA - IEL 17 4%
Active esophagitis E 3 4% Focal active inflammation 15 4%
Lymphocytic gastritis S 2 3% Peptic injury 11 3%
Helicobacter pylori S 2 3% Celiac disease 4 1%
Other gastric S 2 3% Chronic duodenitis 3 1%
Reflux, EE E 2 3% Intramucosal granulomas 2 1%
Ilietis I 2 3% Ulcer 1 0.3%
Active colitis C 2 3% Mild increased lymphocytes 1 0.3%
Other colon C 2 3%    
Lymphocytic colitis C 1 1%    
  1. Results were tabulated for 409 patients with pre-biopsy serologic results and multiple biopsy sites. S = stomach. E = esophagus. I = ileum. C = colon. “Other gastric” includes erosive gastritis and a gastric polyp. “Other colon” includes tubular adenoma and mucosal prolapse. % is based on the number of patients in each serologic category.